Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7460 p46
14 July 2007

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• White Paper
• Pfizer (2)
• Supervision (2)
• Community pharmacy (2)
• Antimicrobials
• Dispensing errors
• Recalls
• Onlooker
• CPPE
• Recycling
• Retention fee


Letters to the Editor

Retention fee

Unfairly treated

From Ms C. Schweizer, MRPharmS

Exactly that same thought went through my mind when I read the note about the announcement by Hemant Patel in the PJ (26 May, p624). I completely agree with Paul Breame and the points he raised in his letter (PJ, 16 June, p706).

The retention fee has risen “substantially” already over the past few years.

I personally think that newly registered pharmacists, those who work part-time or who are having a career break, eg, those on maternity leave, are treated unfairly by having to pay the same fee as everybody else. During a recent update session on pharmacy legislation, I asked a representative of the Royal Pharmaceutical Society the same questions about why the fee cannot be paid monthly and why it cannot be a percentage of the salary. After all, we live in a democracy, ie, people who earn less pay less tax and contribute to society according to their means. I was told that, for legal reasons, the fee must be paid in full and at the beginning of the year.

Furthermore, I was told that every member gets the same support from the Society and must therefore pay the same fee. I imagine that the support includes continuing professional development, ie, the provision of a website to record CPD and the checking of compliance with CPD requirements. If that is the case, why not, hypothetically, split the fee into a set CPD contribution, a set payment for the PJ and the actual registration fee, which is determined according to the earnings of the individual pharmacists? After all, before the introduction of CPD it was possible to set different levels of fees taking into account the earnings.

In other European countries, eg, Germany it is possible to pay the fee quarterly.

As a pharmacist working for the NHS, I feel disadvantaged even further as my employer does not pay my fee unlike some private pharmaceutical employers do.

Cornelia Schweizer
Bangor, Gwynedd

Send your letter to The Editor

Previous Topic (Recycling)

Back to Top


©The Pharmaceutical Journal